Salix Pharmaceuticals
FDA Inspections Database

Salix Pharmaceuticals

FDA Inspections Database

U.S. FDA inspection classifications and citation records from the official FDA inspection database.

NAI · No Action Indicated United States
  • Total Records 7
  • Latest Inspection 2015-03-09
  • Data Source U.S. FDA
  • Last Updated -
Company Overview

Company

Salix Pharmaceuticals

Country

U.S.A

Website

Visit Website

Email

Salixmc@dlss.com

Social Profiles

LinkedIn
Company Snapshot

Salix Pharmaceuticals

400 Somerset Corporate Blvd. Bridgewater, NJ 08807 USA

U.S.A

www.salix.com/ Salixmc@dlss.com View on Map
FDA Inspections Timeline (7 records)
2015
09 Mar
No Action Indicated NAI

Legal Name

Salix Pharmaceuticals Inc

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2015-03-09

FMD Date

-

Fiscal Year

2015

State

North Carolina

Raleigh, United States

Additional Details

Postmarket Adverse Drug Experience (PADE)

Location

Raleigh, North Carolina, United States

Inspection Info

Fiscal Year: 2015
Citations: No

2013
12 Sep
No Action Indicated NAI

Legal Name

Santarus Inc

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2013-09-12

FMD Date

-

Fiscal Year

2013

State

California

San Diego, United States

Additional Details

Postmarket Adverse Drug Experience (PADE)

Location

San Diego, California, United States

Inspection Info

Fiscal Year: 2013
Citations: No

2012
05 Dec
No Action Indicated NAI

Legal Name

Santarus Inc

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2012-12-05

FMD Date

-

Fiscal Year

2013

State

California

San Diego, United States

Additional Details

Sponsor, Contract Research Organization

Location

San Diego, California, United States

Inspection Info

Fiscal Year: 2013
Citations: No

2012
23 May
No Action Indicated NAI

Legal Name

Salix Pharmaceuticals Inc

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2012-05-23

FMD Date

-

Fiscal Year

2012

State

North Carolina

Raleigh, United States

Additional Details

Sponsor, Contract Research Organization

Location

Raleigh, North Carolina, United States

Inspection Info

Fiscal Year: 2012
Citations: No

2011
14 Feb
No Action Indicated NAI

Legal Name

Salix Pharmaceuticals Inc

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2011-02-14

FMD Date

-

Fiscal Year

2011

State

North Carolina

Raleigh, United States

Additional Details

Sponsor, Contract Research Organization

Location

Raleigh, North Carolina, United States

Inspection Info

Fiscal Year: 2011
Citations: No

2010
15 Sep
No Action Indicated NAI

Legal Name

Salix Pharmaceuticals Inc

Project Area

Bioresearch Monitoring

Product Type

Drugs

Posted Citations

No

Inspection End Date

2010-09-15

FMD Date

-

Fiscal Year

2010

State

North Carolina

Raleigh, United States

Additional Details

Postmarket Adverse Drug Experience (PADE)

Location

Raleigh, North Carolina, United States

Inspection Info

Fiscal Year: 2010
Citations: No

2009
11 Dec
No Action Indicated NAI

Legal Name

Santarus Inc

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2009-12-11

FMD Date

-

Fiscal Year

2010

State

California

San Diego, United States

Location

San Diego, California, United States

Inspection Info

Fiscal Year: 2010
Citations: No

Related Databases
  • FDA Inspections
    7 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    30 View
  • Drug Prices in Switzerland
    0 View
Classification Breakdown
7 total
  • NAI (No Action Indicated)
Official Source

All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.

Visit FDA.gov
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Location

Raleigh, North Carolina, United States

Inspection Info

Fiscal Year: 2015
Citations: No

100% Official Data

Directly from the U.S. FDA inspection database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

FDA inspection data is compiled from publicly available U.S. FDA inspection classification records.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit